Categories: Blog

Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details

The Centre has issued a detailed advisory on GLP-1 receptor agonist drugs, emphasizing their use for type 2 diabetes and obesity must be strictly under medical supervision. Authorities are increasing regulatory surveillance and warning of strict action against violations in their sale or prescription.

The News Vista

Leave a Comment
Share
Published by
The News Vista
7 months ago

Recent Posts

Jensen Ackles’ 15-acre Texas brewery shut taproom in 2024, beers still sold

Post Content

38 minutes ago

J&K CM Omar Abdullah says cabinet reshuffle in 2-3 days, asks MLAs to stop lobbying for berths

49 minutes ago

IND vs NZ: Vaibhav Sooryavanshi in playing XI, but there’s a twist

India captain Shreyas Iyer won the toss and elected to bowl first against New Zealand…

1 hour ago

Australian umpire’s Ranji sojourn: Planes overhead at Palam, BKC’s red soil pitch

Australian umpire Ben Treloar is experiencing Indian domestic cricket for the first time as part…

1 hour ago

CTI urges Rahul Gandhi to defer Nov 1 INDIA bloc rally, warns of Rs 10,000 crore trade loss – Udayavani

CTI urges Rahul Gandhi to defer Nov 1 INDIA bloc rally, warns of Rs 10,000…

1 hour ago

‘838’ number plate, pool of blood, screams: Chilling video captures daylight murder

In a shocking act of violence in Chhatrapati Sambhajinagar, bystanders witnessed a murder as Devesh…

1 hour ago